HopeStage
Back to all studies
CompletedNCT03189810

Brain Stimulation for Cannabis Use and Cognition in Schizophrenia

About this titleRead the official source — NCT03189810
Device studyAges 18–55Canada
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 1, 2017
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
Centre for Addiction and Mental Health
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural, Device
Locations
Canada
Age range
From 18 Years to 55 Years
Official registry ID
NCT03189810
Official title
Show the full official title

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies